Completed PHASE2 INTERVENTIONAL NCT00283985

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

Phase II Study of an Association of L-asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-type NK-T-cell Lymphoma

Sponsor: University Hospital, Limoges

Conditions Lymphoma, Non-Hodgkin

Interventions Dexamethasone Erwinase Kidrolase Methotrexate

Updated 6 times since 2017 Last updated: Feb 27, 2013 Started: Feb 28, 2006 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00283985, this PHASE2 trial focuses on Lymphoma, Non-Hodgkin and remains completed. Sponsored by University Hospital, Limoges, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Limoges

Data source: University Hospital, Limoges

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Annecy, France , Bordeaux, France , Créteil, France , Dijon, France , Grenoble, France , Lille, France , Limoges, France , Lorient, France , Lyon, France and 8 more locations